nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comparative assessment of the effects of integrin inhibitor cilengitide on primary culture of head and neck squamous cell carcinoma (HNSCC) and HNSCC cell lines
|
Zhang, L. |
|
2019 |
21 |
8 |
p. 1052-1060 |
artikel |
2 |
Cause-specific mortality after a breast cancer diagnosis: a cohort study of 10,195 women in Girona and Tarragona
|
Ameijide, A. |
|
2018 |
21 |
8 |
p. 1014-1025 |
artikel |
3 |
Clinical significance of serum EGFR gene mutation and serum tumor markers in predicting tyrosine kinase inhibitor efficacy in lung adenocarcinoma
|
Feng, L. X. |
|
2019 |
21 |
8 |
p. 1005-1013 |
artikel |
4 |
Common misconceptions in the prognostic evaluation of clinically stable patients with febrile neutropenia and solid tumors
|
Carmona-Bayonas, A. |
|
2019 |
21 |
8 |
p. 1112-1114 |
artikel |
5 |
Cost–utility analysis of germline BRCA1/2 testing in women with high-grade epithelial ovarian cancer in Spain
|
Moya-Alarcón, Carlota |
|
2019 |
21 |
8 |
p. 1076-1084 |
artikel |
6 |
Critical evaluation of platelet size as a prognostic biomarker in colorectal cancer across multiple treatment settings: a retrospective cohort study
|
Barth, D. A. |
|
2019 |
21 |
8 |
p. 1034-1043 |
artikel |
7 |
Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study
|
Amraee, A. |
|
|
21 |
8 |
p. 1093-1103 |
artikel |
8 |
Efficacy of nivolumab as checkpoint inhibitor drug on survival rate of patients with relapsed/refractory classical Hodgkin lymphoma: a meta-analysis of prospective clinical study
|
Amraee, A. |
|
2019 |
21 |
8 |
p. 1093-1103 |
artikel |
9 |
Efficacy of rechallenge with BRAF inhibition therapy in patients with advanced BRAFV600 mutant melanoma
|
Viñal, D. |
|
2019 |
21 |
8 |
p. 1061-1066 |
artikel |
10 |
Identification a novel set of 6 differential expressed genes in prostate cancer that can potentially predict biochemical recurrence after curative surgery
|
Li, F. |
|
2019 |
21 |
8 |
p. 1067-1075 |
artikel |
11 |
Incidence of sleep problems and their mediating role on depression and anxious preoccupation in patients with resected, non-advanced cancer: data from NEOcoping study
|
Calderon, C. |
|
2019 |
21 |
8 |
p. 1104-1107 |
artikel |
12 |
Letrozole improves the sensitivity of breast cancer cells overexpressing aromatase to cisplatin via down-regulation of FEN1
|
Wang, Y. |
|
2019 |
21 |
8 |
p. 1026-1033 |
artikel |
13 |
Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers: pooled data from three independent cohorts
|
Westphalen, C. B. |
|
2019 |
21 |
8 |
p. 1108-1111 |
artikel |
14 |
Positive nonsentinel lymph nodes are associated with poor survival in breast cancer: results from a retrospective study
|
Si, P. |
|
2019 |
21 |
8 |
p. 1085-1092 |
artikel |
15 |
Survival after biochemical failure in prostate cancer treated with radiotherapy: Spanish Registry of Prostate Cancer (RECAP) database outcomes
|
González-San Segundo, C. |
|
2019 |
21 |
8 |
p. 1044-1051 |
artikel |
16 |
The RANK–RANKL axis: an opportunity for drug repurposing in cancer?
|
Peters, S. |
|
2019 |
21 |
8 |
p. 977-991 |
artikel |
17 |
The role of immunotherapy in small cell lung cancer
|
Calles, A. |
|
2019 |
21 |
8 |
p. 961-976 |
artikel |
18 |
Time for radioimmunotherapy: an overview to bring improvements in clinical practice
|
Leaman Alcibar, O. |
|
2019 |
21 |
8 |
p. 992-1004 |
artikel |